450
Views
23
CrossRef citations to date
0
Altmetric
Celiac Disease

An excess of prior irritable bowel syndrome diagnoses or treatments in Celiac disease: evidence of diagnostic delay

, , &
Pages 801-807 | Received 17 Oct 2012, Accepted 10 Mar 2013, Published online: 22 May 2013
 

Abstract

Objective. It is recognized that celiac disease can present with symptoms characteristic of irritable bowel syndrome (IBS) and that a substantial proportion of patients referred to gastroenterologists with these symptoms may have celiac disease. The authors set out to discover how commonly those suffering with celiac disease are misdiagnosed as suffering from IBS and whether such misdiagnosis delays the correct diagnosis. Materials and methods. A case control study using computerized records from the General Practice Research Database was conducted. The authors compared the proportion of patients with celiac disease who had a diagnosis of or had undergone treatment for IBS over a variety of time periods before the diagnosis of celiac disease with the proportion of a matched group without celiac disease who were similarly diagnosed or treated. Results. It was found that 16% of celiac patients had such a prior diagnosis compared to 4.9% of controls (a threefold increased risk of prior IBS; OR = 3.8, 95% CI: 3.6–4.2), and that if one looked at typical treatment for IBS rather than diagnostic codes, 28% of celiac patients appeared to have been treated compared to 9% of controls. Many of the diagnoses of IBS occurred within the last year before diagnosis of celiac disease, but there was a clear excess of IBS even 10 years earlier. Conclusions. In contemporary UK practice, it is likely that at least some patients with celiac disease spend many years being treated as having IBS. Following guidelines to test serologically for celiac disease will minimize this problem.

Acknowledgments

The study was conceived by Dr Card; all authors contributed to study design and planning. Dr Fleming carried out the analysis. All authors had access to the data and contributed to the interpretation. Drs Fleming and Card produced the first draft which was critically reviewed by all authors. All authors approved the final manuscript.

Declaration of interest: This work was funded by a grant from Coeliac, UK. The funders had no role in the design, analysis, or interpretation. TC has received expenses for speaking at a meeting from Coeliac, UK, and JW has received support for previous unrelated research from the same source and is a voluntary member of their Health Advisory Network; no other relationships or activities that could appear to have influenced the submitted work are declared.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.